Feverfew and ginger, delivered sublingually, were effective in preventing migraine progression when administered at the mild pain phase of the acute attack.
Two hours after treatment, 48% of patients were pain free and another 34% had only mild headache pain.
No significant side effects were reported.
A combination of ginger and feverfew, when administered sublingualy at the mild pain phase, was found to be both safe and effective at relieving the pain and associated symptoms of migraine.
Gelstat Migraine for acute treatment of migraine when administered during the mild pain phase.
Summary of the abstract
Treatment of migraine headaches is often delayed while patients evaluate the severity of an emerging migraine, due to a desire to avoid unwanted side effects of prescription medications, or secondary to cost concerns. Studies have shown better improved pain-free response when treatments are administered early in the course of an attack, during the mild headache phase of migraine. This study was designed to evaluate the benefit of GelStat Migraine in the early treatment of migraine.
Two hours after treatment with GelStat Migraine, just under half of patients were pain-free, and an additional 35% had only a mild headache.
GelStat Migraine was found to be effective as a first line, acute therapy for migraine when initiated early in the course of the attack, at the mild pain phase.